Vyasa Layar Now Available on SAP® Store

Vyasa, an innovative provider of highly scalable deep learning AI analytics software for healthcare, life sciences, and business applications, announced today the availability of its Vyasa Layar offering on SAP® Store, the online marketplace for SAP and partner offerings. Through Vyasa Layar data fabric, users can connect to Sybase® and to SAP Business Technology Platform (SAP BTP) with SAP HANA® to create a unified data experience regardless of data format or storage location.

Tjoapack doubles packaging capacity with completed Netherlands facility expansion

Global pharmaceutical contract packaging organisation (CPO), Tjoapack has announced the completion of its expansion plans following a €10m+ plus investment at its Etten-Leur facility in the Netherlands.

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Former Vice Dean at East Carolina University’s Brody School of Medicine brings scientific and strategic expertise to lead the federally funded clinical research enterprise of this international CRO. Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division. For over 30 years, Rho has worked closely with NIH/NIAID and other federal departments on groundbreaking clinical trial and epidemiologic studies, including the LEAP peanut allergy study. “I am thrilled to welcome Dr. Schmidt to Rho," said Dr. Laura Helms Reece, CEO, Rho. “He is a preeminent neuroscientist and recognized leader across federal, commercial and academic arenas. His expertise in clinical research is remarkable, and his command of central nervous system, infectious disease, and other indications is a great fit with Rho’s focus in those areas. I am eager to work with Dr. Schmidt as he brings exciting strategic and scientific leadership to our federal business. His experience and judgment will be great additions to our Executive Committee.”

Recipharm completes US biologics acquisitions

Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.

Bora Pharmaceuticals to expand operations with $10m+ investment

Huateng Pharma Develops COVID-19 Drug Paxlovid & Ensitrelvir Intermediates

Huateng Pharma is a full-service Contract Development Manufacturing Organizations (CDMO) for pharmaceutical intermediates, including paxlovid and ensitrelvir intermediates.

Global Single-Cell Analysis Market valued at USD 2.1 billion (2020), is growing at a healthy CAGR of 17.8% through the forecast period 2020-2025

Medi-Tech Insights offers an interesting research report on Global Single-Cell Analysis Market. The market growth is likely to be driven by emerging life science and oncology research.

Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

BOC Sciences Unveils Comprehensive Custom Synthesis Services

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

List Bio Raises $48.4 Million Series A for Global Scale-Up

List Bio will use an $48.4 million Series A investment to build a large-scale manufacturing facility in Fishers, Indiana, USA

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Scitara™ Digital Lab Exchange DLX™ Gains ISO Certification and Advances the Modern Lab with the Latest Release of its Barrier-Breaking Lab Integration Platform

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.

Kyruus and Hyro Form Partnership to Help Healthcare Organizations Boost Online Conversion through Digital Self-Service

Partnership will Enable Healthcare Organizations to Enhance Conversational AI Experiences with Robust Provider Search and Scheduling Capabilities

Kyruus and Upfront Partner to Enable Healthcare Organizations to Maximize Digital Patient Acquisition and Retention

Partnership Offers Consumer-Centric Search and Scheduling Options While Closing Gaps in Care through Personalized Digital Outreach to Patients

Exogene raises $2 million for its AI platform to discover cell therapies for cancer

Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.

Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022

NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System

First-of-its-kind automated ultrasound platform now part of PerkinElmer portfolio aims to accelerate preclinical research